MYELOFIBROSIS (MF)

Clinical trials for MYELOFIBROSIS (MF) explained in plain language.

Never miss a new study

Get alerted when new MYELOFIBROSIS (MF) trials appear

Sign up with your email to follow new studies for MYELOFIBROSIS (MF), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet recruiting 5 Not yet finished but already full! 1 Completed 2

New hope for tough blood cancer: testing combo therapy in global trial

Disease control Ongoing

This study is for adults with myelofibrosis, a rare blood cancer, that has come back or not improved after prior treatment. It compares a new two-drug combination (navitoclax + ruxolitinib) against the current best available treatments to see which is better at reducing spleen si…

Matched conditions: MYELOFIBROSIS (MF)

Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control

Last updated Mar 23, 2026 15:18 UTC

MYELOFIBROSIS (MF)

Get alerted when new MYELOFIBROSIS (MF) trials appear

New hope for tough blood cancer: testing combo therapy in global trial